Advances in Metered Dose Inhaler Technology with the Development of a Chlorofluorocarbon-Free Drug Delivery System

1999 ◽  
Vol 12 (3) ◽  
pp. 151-160 ◽  
Author(s):  
DANNA L. ROSS ◽  
BRIAN J. GABRIO
Author(s):  
Jaideep Gogtay ◽  
Amol Tambe ◽  
Kiran Rote ◽  
Geena Malhotra ◽  
Braj Gaurav Sharma ◽  
...  

2021 ◽  
pp. 18-19
Author(s):  
Deena. E. ◽  
Ruma Nayak

Objective: To investigate the patient satisfaction and the acceptability of salbutamol through Metered Dose Inhaler (MDI) in the treatment of wheeze in asthma. 34 participants between ages of 5 and 18 years were incl Methods: uded. Modied Pulmonary Index (MPI) score was used to assess the improvement after treatment with salbutamol delivered by inhaler.Pre and post treatment scores were used to assess treatment outcome. Questionnaire was used to assess patient satisfaction by interviewing parents of participants. After the use of inhaler, 12% participants had no change in symptoms Results: , while 6% showing worsening of symptoms. In the remaining 82%, the symptoms reduced. 2.9% were not at all satised with the treatment, while 20.6% were moderately satised with the treatment. 76.5% of the participants were highly satised with the treatment. The use of Metered dose inhaler with salbutamol is very Conclusion: effective in reducing wheeze and other symptoms in asthma. Even those with no improvement in symptoms had high satisfaction with the treatment using salbutamol through MDI. This mode of drug delivery can enhance adherence and asthma control.


1999 ◽  
Vol 237 (5) ◽  
pp. 394-398 ◽  
Author(s):  
M. Diestelhorst ◽  
S. Grunthal ◽  
R. Süverkrüp

Sign in / Sign up

Export Citation Format

Share Document